-
中文名稱：人抗繆勒管激素2型受體(AMHR2)酶聯免疫試劑盒
-
貨號：CSB-EL001667HU
-
規格：96T/48T
-
價格：￥3600/￥2500
-
其他：
產品詳情
-
產品描述：人抗繆勒管激素2型受體(AMHR2)酶聯免疫試劑盒（CSB-EL001667HU）為雙抗夾心法ELISA試劑盒，定量檢測血清、血漿、組織勻漿、細胞裂解物樣本中的AMHR2含量。AMHR2即抗繆勒管激素受體2，在人體生殖系統等發育中發揮重要作用。目前研究聚焦于其在卵巢癌等疾病中的機制，它可能參與細胞增殖、遷移等過程，以其為靶點有望開發新的診斷標志物和治療方法，為相關疾病防治帶來新思路。試劑盒檢測范圍為0.32 ng/mL-12 ng/mL，適用于科研領域中對AMHR2表達水平的定量分析，可用于生殖生物學研究、卵巢功能評估、性別分化機制探索及相關疾病模型的分子機制研究，為生殖系統相關蛋白的功能解析提供可靠工具本品僅用于科研，不用于臨床診斷，產品具體參數及操作步驟詳見產品說明書。
-
別名：AMH type II receptor ELISA Kit; AMHR ELISA Kit; AMHR2 ELISA Kit; AMHR2_HUMAN ELISA Kit; Anti Mullerian hormone receptor; type II ELISA Kit; Anti-Muellerian hormone type II receptor ELISA Kit; Anti-Muellerian hormone type-2 receptor ELISA Kit; MGC141312 ELISA Kit; MIS type II receptor ELISA Kit; MISR2 ELISA Kit; MISRII ELISA Kit; MRII ELISA Kit; Muellerian hormone type 2 receptor ELISA Kit; Muellerian hormone type II receptor ELISA Kit; Muellerian inhibiting substance type II receptor ELISA Kit; Mullerian hormone receptor type II ELISA Kit; Mullerian inhibiting substance type II receptor ELISA Kit
-
縮寫：
-
Uniprot No.：
-
種屬：Homo sapiens (Human)
-
樣本類型：serum, plasma, tissue homogenates, cell lysates
-
檢測范圍：0.32 ng/mL-12 ng/mL
-
靈敏度：8 pg/mL
-
反應時間：1-5h
-
樣本體積：50-100ul
-
檢測波長：450 nm
-
研究領域：Signal Transduction
-
測定原理：quantitative
-
測定方法：Sandwich
-
精密度：
Intra-assay Precision (Precision within an assay): CV%<15% Three samples of known concentration were tested twenty times on one plate to assess. Inter-assay Precision (Precision between assays): CV%<15% Three samples of known concentration were tested in twenty assays to assess. -
線性度：
To assess the linearity of the assay, samples were spiked with high concentrations of human AMHR2 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay. Sample Serum(n=4) 1:1 Average % 92 Range % 86-100 1:2 Average % 95 Range % 90-105 1:4 Average % 92 Range % 84-99 1:8 Average % 96 Range % 90-101 -
回收率：
The recovery of human AMHR2 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section. Sample Type Average % Recovery Range Serum (n=5) 97 92-103 EDTA plasma (n=4) 97 93-105 -
標準曲線：
These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed. 
ng/ml OD1 OD2 Average Corrected 12 2.377 2.354 2.366 2.312 6.4 1.726 1.742 1.734 1.680 3.2 1.053 1.075 1.064 1.010 0.8 0.332 0.327 0.330 0.276 0.32 0.165 0.170 0.168 0.114 0 0.055 0.052 0.054 -
數據處理：
-
貨期：3-5 working days
引用文獻
- Disorders of the glucose metabolism correlate with the phenotype and the severity in women with polycystic ovary syndrome van Helden J,Clin. Endocrinol. (Oxf),2020
- The importance of soluble anti-Mullerian hormone receptor type 2 (sAMHR2) as a new serum marker in diagnosis of fertility disorders in women Lena Sophie Olivier, et al,Reproductive Biomedicine Online,2019
產品評價
相關產品
靶點詳情
-
功能：On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for anti-Muellerian hormone.
-
基因功能參考文獻：
- AMHR2 single nucleotide polymorphism is not associated with Endometriosis-associated infertility. PMID: 28831646
- AMHRII 1749C > T and -482A > G genetic variants are associated with the ovarian response to standard gonadotropin stimulation, affecting mainly the follicular growth in IVF. PMID: 26933946
- a result of VEGF misregulation, AMHR2 overexpression increases AMH binding, which may attenuate follicular or oocyte maturation. PMID: 27109000
- -482A > G genotype not associated with estradiol levels, ovarian parameters, menstrual cycle length, or pregnancy outcomes in healthy Singapore women PMID: 26633196
- A significant subset of GnRH neurons express the AMH receptor. PMID: 26753790
- A significant portion of AMHRII was missing most of its extracellular domain (ECD) and was unfolded and retained in the endoplasmic reticulum. PMID: 25663701
- study demonstrated for the first time that human placenta and fetal membranes express and co-localize Anti-Mullerian hormone(AMH) and Anti-Mullerian hormone Receptor II PMID: 25972076
- AMHR2 rs11170555 and rs3741664 were positively associated with AMH, estradiol and FSH levels. PMID: 25790842
- Data indicate that Muellerian inhibiting substance type II receptor (MISRII) is a promising target for the control of ovarian granulosa cell tumors (GCT) and epithelial ovarian cancers (EOC). PMID: 25517316
- The possible involvement of AMHRII -482 A>G polymorphism on the malfunction of follicular development in Japanese women. PMID: 24271023
- Antimullerian hormone receptor expression is increased in endometrium from patients with endometriosis. PMID: 24613539
- Within primary ovarian insufficiency population, the AMH Ile(49)Ser and the AMHR2 -482A>G polymorphisms were not associated with age at the time of POI and PMID: 24146295
- The role of the AMHR2 -482 A>G gene polymorphism in the pathogenesis of polycystic ovary syndrome was suggested by the association of the variant with risk. PMID: 23969185
- likely molecular etiology was found in eight patients with persistent Mullerian duct syndrome. Four mutations in AMH and two in AMHR2 were identified. Three of them are novel mutations, c.556-2A>G, and p.Arg502Leu in AMH; and p.Gly323Ser in AMHR2. PMID: 23295284
- Data suggest that up-regulation of AMHR2 and AMH expression in luteal granulosa cells of anovulatory women with polycystic ovary syndrome is due to rising levels of luteinizing hormone (LH) and/or reversal of down-regulation by LH. PMID: 23321213
- The Mullerian inhibiting substance type 2 receptor suppresses tumorigenesis in testes with sustained beta-catenin signaling. PMID: 22962306
- the diversity of clinical symptoms within sibship and lack of correlation between development of Mullerian derivatives and severity of molecular defects suggest highly variable penetrance of abnormal alleles PMID: 22584735
- Association studies of common variants of AMHRII suggests that antimullerian hormone may regulate the primordial graafian follicle recruitment. PMID: 20362961
- Review. The role of AMHR2 in gonadal development and its mutation in the persistent Mullerian duct syndrome is discussed. PMID: 12462075
- binding domains recognized by a monoclonal antibody and the natural ligand PMID: 14750901
- The observed association of the AMHR2 -482 A > G polymorphism with natural age at menopause suggests a role for AMH signaling in the usage of the primordial follicle pool in women. PMID: 17636279
- MISIIR is highly expressed by a wide variety of gynecologic cancers, including cancers currently without effective systemic therapies. PMID: 17988723
- Reduced AMH receptor type 2 is associated with Leydig cell tumours in multiple endocrine neoplasia type 1 PMID: 18310289
- Non-epithelial malignant ovarian tumors showed stronger expression of anti-Mullerian hormone receptor type II than that of epithelial tumors. PMID: 19424576
- Mutations of AMHR2 found in persistent Mullerian duct syndrome affect its ligand binding and cellular transport. PMID: 19457927
- interacts with Mullerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications. PMID: 11588147
顯示更多
收起更多
-
相關疾病：Persistent Muellerian duct syndrome 2 (PMDS2)
-
亞細胞定位：Membrane; Single-pass type I membrane protein.
-
蛋白家族：Protein kinase superfamily, TKL Ser/Thr protein kinase family, TGFB receptor subfamily
-
數據庫鏈接：
Most popular with customers
-
Human Transforming Growth factor β1,TGF-β1 ELISA kit
Detect Range: 23.5 pg/ml-1500 pg/ml
Sensitivity: 5.8 pg/ml
-
-
-
Mouse Tumor necrosis factor α,TNF-α ELISA Kit
Detect Range: 7.8 pg/ml-500 pg/ml
Sensitivity: 1.95 pg/ml
-
-
-
-
